Skip to main content

Ankle–Brachial Pressure Index (ABPI)



Ankle–Brachial Pressure Index (ABPI)

Definition

Ankle–Brachial Pressure Index (ABPI), also called Ankle–Brachial Index (ABI), is a simple, non-invasive bedside test that compares systolic blood pressure at the ankle with systolic blood pressure at the brachial artery to assess lower-limb arterial perfusion.

---

Principle


Peripheral arterial disease (PAD) causes reduced systolic pressure distal to arterial stenosis or occlusion. Comparing ankle pressure with arm pressure provides an objective estimate of arterial flow to the legs.



---


Formula


ABPI =

Highest ankle systolic pressure (dorsalis pedis or posterior tibial) ÷ Highest brachial systolic pressure


Measured separately for each leg.



---


Methods of Measuring ABPI


1. Doppler-Assisted ABPI (Gold Standard)


Equipment


Hand-held Doppler (8–10 MHz)


Sphygmomanometer cuffs (appropriate size)



Steps


1. Patient rests supine for ≥10 minutes



2. Measure systolic BP in both brachial arteries using Doppler



3. Measure systolic BP at:


Dorsalis pedis artery


Posterior tibial artery




4. Use the higher ankle pressure and higher brachial pressure for calculation




Advantages


Most accurate bedside method


Widely recommended in guidelines



Limitations


Requires operator skill


Time-consuming in busy clinics




---


2. Automated Oscillometric ABPI


Description


Automated BP devices measure arm and ankle pressures simultaneously or sequentially



Advantages


Quick


Minimal training required



Limitations


Less accurate in:


Diabetes


Chronic kidney disease


Severe PAD



May underestimate disease severity




---


3. Toe–Brachial Index (TBI) (When ABPI is Unreliable)


Indications


Non-compressible arteries (ABPI >1.3)


Diabetes mellitus


Medial arterial calcification



Normal TBI


≥0.7




---


Interpretation of ABPI


ABPI Value Interpretation


1.00 – 1.30 Normal

0.91 – 0.99 Borderline

0.41 – 0.90 Mild–Moderate PAD

≤0.40 Severe PAD

>1.30 Non-compressible arteries




---


Clinical Uses of ABPI


1. Diagnosis of Peripheral Arterial Disease


Detects symptomatic and asymptomatic PAD


Correlates with angiographic disease severity



2. Cardiovascular Risk Stratification


Low ABPI is an independent predictor of:


Myocardial infarction


Stroke


Cardiovascular mortality




3. Assessment of Leg Pain


Differentiates vascular claudication from:


Neurogenic claudication


Musculoskeletal pain




4. Wound and Ulcer Assessment


Guides safety of compression therapy in venous ulcers


Predicts wound healing potential



5. Pre- and Post-Revascularization Evaluation


Baseline assessment before intervention


Objective follow-up after angioplasty or surgery




---


Contraindications / Cautions


Severe leg pain or acute limb ischemia (do not delay urgent care)


Incorrect cuff size can produce false results


Calcified arteries may falsely elevate ABPI




---


Factors Affecting Accuracy


Diabetes mellitus


Chronic kidney disease


Advanced age


Edema


Improper patient positioning




---


Key Points


ABPI is a rapid, inexpensive, and non-invasive test


Doppler-assisted method is preferred for accuracy


Abnormal ABPI indicates both limb ischemia and systemic atherosclerosis


High values (>1.3) are not normal and require alternative assessment




---


For more cardiology infographics and articles, visit: drmusmanjaved.com


Labels:

Comments

Post a Comment

Drop your thoughts here, we would love to hear from you

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...
1 comment
Latest Posts »

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

 𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.
1 comment
Latest Posts »

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...
Post a Comment
Latest Posts »